Phibro Animal Health | PAHC - Ativo Circulante





Ativo Circulante Alterar Data
Align Technology USD 2.66B 38.87M 2026-03
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Henry Schein USD 4.5B 32M 2026-03
Idexx Laboratories USD 1.45B 40.25M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Pacira USD 514.96M 33.01M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Zoetis USD 6.47B 294M 2026-03